UNSPSC 51121583: Propafenone hydrochloride

This classification denotes a cation channel blocker and antiarrhythmic agent with the molecular formula C21H27NO3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 33XCH0HOCD, chemically known as 1-propanone, 1-(2-(2-hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl- but more generally known as propafenone hydrochloride, which bears US NIH Compound Identifier 4932. European Medicines Agency schedules Propafenone hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04077MIG.

UNSPSC 51121583 Propafenone hydrochloride, a Commodity code, addresses advanced cardiac life support medications sourced by fire departments, emergency medical services, health agencies, and cooperative purchasing coalitions across state and local jurisdictions. State and local governments procure this specific antiarrhythmic drug as part of broader medication supply contracts to support emergency response operations and pharmacy benefit programs. Issuing bodies include city fire departments (such as Tampa Fire Rescue through the City of Tampa's Purchasing Department), state health and human services commissions (notably the Texas HHS Commission), and multistate cooperative purchasing alliances such as MMCAP. The work consists of supplying pharmaceutical-grade propafenone hydrochloride in specified concentrations and packaging formats, with mandatory compliance to FDA requirements, Good Manufacturing Practices, Drug Supply Chain Security Act standards, Safety Data Sheets, and expiration-date guarantees typically ranging from nine months to one year from date of acceptance or manufacture.

Recent activity concentrated in Texas, Florida, and Minnesota reflects typical geographic distribution. The City of Tampa's Purchasing Department issued IFB 26P00188 on April 24, 2026, for Advanced Life Support Medications (due April 8, 2026) with an estimated contract value of $40,000, procuring four specific medication line items including adenosine and diltiazem for Tampa Fire Rescue with a one-year term and optional two-year renewals. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, gathering vendor capabilities for direct-to-manufacturer prescription programs to inform future formal solicitation strategy. The Minnesota Department of Administration's Office of State Procurement, administering MMCAP, issued RFP S1070000015802 (due March 26, 2026) to establish statewide and interstate contracts for generic multi-source pharmaceuticals and OTC products distributed through AmerisourceBergen, Cardinal Health, and Morris & Dickson, with evaluation weighted 75 percent on price competitiveness and contract terms effective July 1, 2026.